October 26, 2015
Strensiq: First approved treatment for perinatal
Strensiq is the first treatment for perinatal, infantile and juvenile-onset hypophosphatasia (HPP) approved approved by FDA.
Pharmaceuticals, Biotechnology and Life Sciences
Strensiq is the first treatment for perinatal, infantile and juvenile-onset hypophosphatasia (HPP) approved approved by FDA.